Interview 5 Apr 2021 Base Editing: The Next Frontier in Genome Editing Technology Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base editing technology. In less than a decade, the advent of CRISPR-Cas9 has made gene editing easier and faster than ever. But CRISPR, as well as earlier genome editing tools, have a series of technical limitations, […] April 5, 2021 - 4 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 1 Apr 2021 Have European Investors Missed the Exosome ‘Gold Rush’? When Oxford-based Evox Therapeutics announced its €81.1M (£69.2M) Series C round in February, it signaled that investors are taking exosome therapies seriously. But a lack of European investors in the exosome field raises the very real possibility that the best opportunities have already passed, along with the chance to build an exosome ecosystem to rival […] April 1, 2021 - 5 minutesmins - By Mark Zipkin Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2021 Lava Therapeutics’ IPO Shakes Cancer Niche of Gamma Delta T Cells The Dutch biotech startup Lava Therapeutics launched onto the Nasdaq stock market last week with an €85.6M ($100.5M) IPO. This is a sign of mounting investor interest in cancer treatments based on immune cells known as gamma delta T cells. The proceeds of the IPO will be used to drive the development of the company’s […] March 31, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 31 Mar 2021 Equity Crowdfunding for Biotech Startups: Does It Work? In the last decade, crowdfunding has become a popular way to finance all sorts of projects and products. Biotech is no exception, but many question whether the high risk and long term nature of investing in the biotech industry makes it a good fit for equity crowdfunding. When you hear the term crowdfunding, you might […] March 31, 2021 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Mar 2021 The 25 Best Biotech Incubators Hatching Startup Stars in Europe Incubators can give biotech startups the boost they need to get off the ground. These are our top picks of the biotech incubators across Europe supporting the next generation of life science startups. Creating a biotech company is a challenging, long-term endeavor. In particular, the first steps can be essential to set up a new […] March 29, 2021 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Mar 2021 Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in other fields like cancer or gene therapy. However, complex challenges remain, such as circumventing immunity to adenoviral treatments. Earlier this month, Johnson & Johnson’s candidate became the first single-shot Covid-19 vaccine to get the EMA green light. The vaccine is […] March 25, 2021 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2021 Global Funding for Meat Alternative Companies Tripled in 2020 Companies developing sustainable meat and dairy alternatives smashed records with a €2.6B ($3.1B) haul last year. Why has it been such a bumper harvest? Traditional agriculture is a major polluter, especially in the case of meat production. The highest estimations place its share of global greenhouse gas emissions at up to 20%. In an effort […] March 24, 2021 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 24 Mar 2021 How to Negotiate a Successful Research Collaboration Agreement Negotiating the terms of a research collaboration can be a minefield. Life sciences attorney Lori Waldron shares her extensive experience helping biotech and pharma companies negotiate agreements. Amid a dramatic increase in funding research and development in the medical biotech sector, both larger pharmaceutical companies looking to diversify their portfolios and startups looking for a […] March 24, 2021 - 9 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
In Depth 22 Mar 2021 Can Immunotherapy Offer Hope for Parkinson’s Sufferers? Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally provide a solution? More than seven million people worldwide are currently living with Parkinson’s disease, an incurable neurodegenerative disorder. Current treatment options are limited as they only attempt to mask the symptoms rather than address the cause. But there is […] March 22, 2021 - 5 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 18 Mar 2021 Europe Falls Behind in Efforts to Track Covid-19 Variants As barely a third of European countries meet targets to track concerning Covid-19 variants, diagnostics and genomics companies are scrambling to help them tackle this challenge. New strains of the Covid-19 coronavirus are sweeping Europe as vaccine distribution efforts roll on. These variants often gain traction when mutations let them become more virulent or spread […] March 18, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
In Depth 17 Mar 2021 Feed Additives Put the Brakes on Cattle Methane Emissions Research into how feed additives interact with the gut microbiome of cattle is paving the way towards a new strategy to tackle one of the main contributors to global warming. Feeding over seven billion people comes with a massive carbon footprint. The agriculture sector demands the clearing of large areas of forests. Unsustainable agricultural practices […] March 17, 2021 - 8 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
Interview 15 Mar 2021 Developing a Vaccine that Protects Against Covid-19 Variants Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs around the world, recent mutations in the virus causing Covid-19 are raising concern. Can the current vaccines protect against different coronavirus variants? Paul Higham became CEO of the Finnish firm Valo Therapeutics in 2020. The company was founded in 2016 […] March 15, 2021 - 8 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email